winrevair
(SOTATERCEPT-CSRK)Merck Sharp & Dohme LLC
Usage: WINREVAIR™ is indicated for adults with pulmonary arterial hypertension (PAH, WHO Group 1) to enhance exercise capacity, improve functional class, and decrease the risk of clinical worsening events.